We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics

News   Jul 05, 2013

 
ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics
 
 
Advertisement
 

RELATED ARTICLES

Creating an Artificial Energy Source To Power Muscles

News

A new study in the Biophysical Journal outlines the work of scientists who have created a series of compounds that could serve as an alternative synthetic energy source for myosin.

READ MORE

A Mirror-image Peptide Tumor Treatment

News

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.

READ MORE

Accelerated Discovery of Bioactive Components in Seaweed

News

Using state-of-the-art approaches coupled with bio- and cheminformatics and machine learning, researchers at the GEOMAR Helmholtz Centre for Ocean Research Kiel have succeeded in discovering new, bioactive components of the Baltic Sea seaweed Fucus vesiculosus and its fungal symbiont against infectious bacteria or skin cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE